Bayesian PK/PD Dosing — 3D

Population pharmacokinetic priors refined by an individual patient's own drug-level measurements (TDM) via Bayesian forecasting — the population uncertainty is now a literal spatial dimension you can orbit around.

Current Stage

—

Clearance (CL)

—

AUC₂₄

—

Predicted Trough

—

Posterior CV%

—

Renal Function (CrCl)90 mL/min

TDM Samples Collected1

Dose per Interval1000 mg

Population cloud (16 sampled clearances, fanned in depth)

Observed TDM level (measured concentration)

Individualized posterior (MAP) curve, front plane

Therapeutic window slab (10–20 mg/L)